Based on the Pro-Dex Inc stock forecast from 1 analysts, the average analyst target price for Pro-Dex Inc is USD 52.00 over the next 12 months. Pro-Dex Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Pro-Dex Inc is Slightly Bullish , which is based on 7 positive signals and 5 negative signals. At the last closing, Pro-Dex Inc’s stock price was USD 58.63. Pro-Dex Inc’s stock price has changed by +6.23% over the past week, +46.28% over the past month and +229.01% over the last year.
No recent analyst target price found for Pro-Dex Inc
No recent average analyst rating found for Pro-Dex Inc
Company Overview Pro-Dex Inc
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California. Read Less
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily u...Read More
Frequently Asked Questions About Pro-Dex Inc (PDEX) Stock
Based on ratings from 1 analysts Pro-Dex Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on PDEX's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PDEX is USD 52.00 over the next 12 months. The maximum analyst target price is USD 52 while the minimum anlayst target price is USD 52.
PDEX stock's Price/Earning ratio is 25.34.
Our analysis grades PDEX stock's Price / Earning ratio at F. This means that PDEX stock's Price/Earning ratio is above 41% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this PDEX may be fairly valued for its sector
The last closing price of PDEX's stock was USD 58.63.
The most recent market capitalization for PDEX is USD 0.16B.
Based on targets from 1 analysts, the average taret price for PDEX is projected at USD 52.00 over the next 12 months.
This means that PDEX's stock price may go down by -11.31% over the next 12 months.
We can't find any ETFs which contains Pro-Dex Inc's stock.
As per our most recent records Pro-Dex Inc has 146 Employees.
Pro-Dex Inc's registered address is 2361 McGaw Avenue, Irvine, CA, United States, 92614.
You can get more information about it from Pro-Dex Inc's website at https://www.pro-dex.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Pro-Dex Inc (PDEX) Stock
Based on ratings from 1 analysts Pro-Dex Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on PDEX's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PDEX is USD 52.00 over the next 12 months. The maximum analyst target price is USD 52 while the minimum anlayst target price is USD 52.
PDEX stock's Price/Earning ratio is 25.34.
Our analysis grades PDEX stock's Price / Earning ratio at F. This means that PDEX stock's Price/Earning ratio is above 41% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this PDEX may be fairly valued for its sector
The last closing price of PDEX's stock was USD 58.63.
The most recent market capitalization for PDEX is USD 0.16B.
Based on targets from 1 analysts, the average taret price for PDEX is projected at USD 52.00 over the next 12 months.
This means that PDEX's stock price may go down by -11.31% over the next 12 months.
We can't find any ETFs which contains Pro-Dex Inc's stock.
As per our most recent records Pro-Dex Inc has 146 Employees.
Pro-Dex Inc's registered address is 2361 McGaw Avenue, Irvine, CA, United States, 92614.
You can get more information about it from Pro-Dex Inc's website at https://www.pro-dex.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PDEX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
